The first Joint Clinical Assessment reports reveal new expectations for pharmaceutical evidence planning. Explore the implications for trial design, PICO anticipation, cross-functional governance, and AI-enabled HTA readiness.
AI is changing how clinical data is managed, programmed, and interpreted. Explore the implications for clinical data professionals, connected workflows, and the operating models needed to support lasting value.
Most-FavoredNation’s GlobalImpact: The Futureof Drug Pricing
As a full-service consulting firm, we have deep expertise in the Financial Services industry. Combined with the possibilities of exponential technology, we deliver solutions that will elevate your business and keep you ahead of the competition.
BIP Life Sciences at the Forefront of Innovation and Inclusion BIP was honored to participate in the 17th Advancing Women’s Leadership in Pharma & Healthcare